APA (7th ed.) Citation

Brahmer, J., Reckamp, K. L., Baas, P., Crinò, L., Eberhardt, W. E. E., Poddubskaya, E., . . . Paz-Ares, L. (2015). Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer. New England Journal of Medicine, 373(2), 123. https://doi.org/10.1056/NEJMoa1504627

Chicago Style (17th ed.) Citation

Brahmer, Julie, et al. "Nivolumab Versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer." New England Journal of Medicine 373, no. 2 (2015): 123. https://doi.org/10.1056/NEJMoa1504627.

MLA (9th ed.) Citation

Brahmer, Julie, et al. "Nivolumab Versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer." New England Journal of Medicine, vol. 373, no. 2, 2015, p. 123, https://doi.org/10.1056/NEJMoa1504627.